Latest news
Loading news…
Ascenta Therapeutics
ActiveOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 LowHeat score — how much recent activity & attention the company has (web traffic, news, hiring).📈 Low growthGrowth score — momentum trend across web traffic, headcount and other growth signals. Malvern, Pennsylvania, United States Founded 2003 51-100 employees For Profit
Ascenta Therapeutics, a clinical-stage biopharmaceutical company, focuses on the discovery and development of new medicines to treat cancer.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
0
Monthly Visits
Available in Pro Contacts
2
Patents
4
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
IPO & Stock
- IPO status
- Private
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Technology & IP
- Active technologies
- 2
- Patents granted
- 4
- Trademarks
- 0
- Top patent class
- Agriculture; Forestry; Animal Husbandry; Hunting; Trapping; Fishing
- IT spend
- $9M
Company Info
- Founded
- 2003
- Employees
- 51-100
- Operating status
- Active
- Company type
- For Profit
- Org types
- company
- Founders
- 3
- News articles
- 6
- HQ
- Malvern, Pennsylvania, United States
- Region
- Greater Philadelphia Area, Great Lakes, Northeastern US
Signals & Scores
- Heat score
- Low
- Growth score
- Low
- Trend (7d)
- 0
- Trend (30d)
- 0
- Trend (90d)
- -0.6
2
professional contacts at Ascenta Therapeutics
Contact execs at Ascenta Therapeutics →Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to Ascenta Therapeutics
Loading news…
FAQs about Ascenta Therapeutics
People who checked this page also checked these
Browse the full Acquirezy directory.